This study assesses the value of novel immuno-oncology treatments to society.
Andrew Delgado, PharmD
Advertisement
Articles by Andrew Delgado, PharmD
Advertisement
Latest Updated Articles
- The Value of Novel Immuno-Oncology Treatments
December 4th 2018
Advertisement
Advertisement
Trending on AJMC
1
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
2
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
3
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
4
Defunding Co-Payment Assistance Disrupted nAMD Care
5